Hrt Financial LP Trinity Biotech PLC Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.43 - $2.25 $19,200 - $30,210	-13,427 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.82 - $2.94 $1,257 - $2,031	-691 Reduced 4.89%	13,427 $29,000
Q2 2021 Aug 16, 2021	BUY	$2.77 - $4.18 $49 - $75	18 Added 0.13%	14,118 $41,000
Q1 2021 May 17, 2021	BUY	$3.26 - $6.64 $45,966 - $93,624	14,100 New	14,100 $53,000
Q4 2020 Feb 16, 2021	SELL	$1.95 - $4.77 $76,217 - $186,440	-39,086 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.68 - $3.17 $24,111 - $45,495	14,352 Added 58.03%	39,086 $78,000
Q2 2020 Aug 14, 2020	BUY	$0.88 - $2.55 $21,765 - $63,071	24,734 New	24,734 $53,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $45.7M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.